Improving the Management of Patients with Asthma through Individualized Care Strategies Webcast

Release date: December 2, 2014
Expiration date: December 2, 2015

Faculty

Rohit K. Katial, MD, FAAAAI, FACP
Program Director
Allergy and Immunology
Professor of Medicine
Department of Medicine
National Jewish Health
Denver, Colorado

Program Overview

Despite the availability of established guidelines for the diagnosis and management of asthma, benchmarks for successful treatment are not being reached, leading to unnecessary personal, physical, emotional, economic, and public health consequences. Even with a wide range of asthma management strategies and effective long-term preventative medications currently available, many patients remain seriously uninformed and misinformed about how to achieve and maintain symptom control for their asthma.

Asthma is a highly variable disease, and care should be individualized on a case-by-case basis. Poorly controlled asthma results in exacerbations and urgent care visits and these events negatively impact patient quality of life and impose significant costs on the healthcare system. In light of this, it is incumbent upon healthcare providers to renew their interest in ongoing concepts in asthma care and how to improve patient outcomes.

Target Audience

This activity has been designed for allergists involved in the treatment of patients with asthma.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the pathophysiologic mechanisms of asthma
  • Implement pharmacologic treatment plans in accordance with evidence-based guidelines for the management of patients with asthma
  • Individualize the treatment of patients with asthma and adjust management strategies based on patient phenotype

Directions to Learner

There are no fees for participating and receiving CME credit for this activity. During the period December 2, 2014 through December 2, 2015, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest by recording the best answer to each question in the answer key on the evaluation form
  • Complete the evaluation form

A statement of credit will be issued upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Your statement of credit will be sent to you within 4 weeks.

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education, Inc. designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Integrity Continuing Education, Inc., requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc., for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities.

Rohit K. Katial, MD, FAAAAI, FACP
Advisory Board: Teva
Speaker: Teva

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Patima Tanapat, PhD, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc., and Sunovion Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc., and Sunovion Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy Policy

When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and...(continued)

Minimum System Requirements

Windows XP, Windows 2000, Windows Vista, and Windows 7 Intel Pentium 4, 2.33 + GHz (or equivalent)
Adobe® Flash® Player 10
For optimal performance, the use of Internet Explorer is not recommended.

Mac OS X v10.4 or later
1.8GHz or faster (or equivalent)
Intel Core Duo 1.33GHz or faster (or equivalent)
Adobe® Flash® Player 10

Click here for more information on minimum system requirements.

Disclaimer

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

begin pretest

pre

For optimal performance, the use of Internet Explorer is not recommended.

integrity
 Sponsored by Integrity Continuing Education, Inc.
Supported by an educational grant from Sunovion Pharmaceuticals, Inc.